Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients
This is a retrospective study. 21 patients with known case primary/recurrent breast carcinoma (BIRADS 4/5 breast lesions) underwent [ 18F]FCH PET/CT prior to biopsy. Histopathological examination (HPE) is obtained and dichotomized into malignant and benign groups and HER2-ve and HER2+ve groups....
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
International Agency Energy Agency (IAEA)
2024
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/120520/ http://psasir.upm.edu.my/id/eprint/120520/1/120520.pdf |
| Summary: | This is a retrospective study. 21 patients with known case primary/recurrent breast carcinoma (BIRADS 4/5 breast lesions) underwent [
18F]FCH PET/CT prior to biopsy. Histopathological
examination (HPE) is obtained and dichotomized into malignant and benign groups and HER2-ve and
HER2+ve groups. Maximum standardized uptake value (SUVmax (g/dl) was used to predict two
groups of variables for cellular breast cancer aggressiveness. QOL assessed SF-36®, SF36v2®, SF-
1,2® and SF-12v2® Health Surveys. Questionnaires used under Medical Outcome Trust and QOL
domains: Global Health Status (GHS), Physical Function (PF), Role Function (RF) and Social
Function (SF). |
|---|